|
2022-08-22 |
2022-08-19 |
B
Purchase
|
Bailey Gregory
Non-Executive Director
|
38,000
+1.5%
148.04
USD 5,625,676
|
38,000
+1.5%
|
148.04
|
USD 5,625,676
|
|
|
2022-05-12 |
2022-05-10 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
4,200
-50.8%
141.50
USD 594,300
|
4,200
-50.8%
|
141.50
|
USD 594,300
|
|
|
2022-01-24 |
2022-01-19 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
3,520
-36.9%
119.37
USD 420,180
|
3,520
-36.9%
|
119.37
|
USD 420,180
|
|
|
2022-01-24 |
2022-01-19 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
500
-5.0%
118.05
USD 59,024
|
500
-5.0%
|
118.05
|
USD 59,024
|
|
|
2022-01-24 |
2022-01-19 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
2,159
-17.7%
116.02
USD 250,485
|
2,159
-17.7%
|
116.02
|
USD 250,485
|
|
|
2022-01-24 |
2022-01-19 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
3,196
-20.8%
114.93
USD 367,314
|
3,196
-20.8%
|
114.93
|
USD 367,314
|
|
|
2021-12-22 |
2021-12-20 |
PS
Planned sale
|
GREGORY JULIA P
Non-Executive Director
|
12,000
-100.0%
125.00
USD 1,500,000
|
12,000
-100.0%
|
125.00
|
USD 1,500,000
|
|
|
2021-12-22 |
2021-12-20 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
1,915
-18.9%
123.84
USD 237,154
|
1,915
-18.9%
|
123.84
|
USD 237,154
|
|
|
2021-12-16 |
2021-12-15 |
PS
Planned sale
|
Stock Elyse
Chief Medical Officer
Officer
|
1,589
-17.5%
106.17
USD 168,701
|
1,589
-17.5%
|
106.17
|
USD 168,701
|
|
|
2021-12-16 |
2021-12-15 |
PS
Planned sale
|
Stock Elyse
Chief Medical Officer
Officer
|
20,330
-69.2%
105.43
USD 2,143,426
|
20,330
-69.2%
|
105.43
|
USD 2,143,426
|
|
|
2021-12-16 |
2021-12-14 |
PS
Planned sale
|
Stock Elyse
Chief Medical Officer
Officer
|
6,939
-48.2%
105.02
USD 728,762
|
6,939
-48.2%
|
105.02
|
USD 728,762
|
|
|
2021-12-10 |
2021-12-10 |
PS
Planned sale
|
Engelhart James
Chief Financial Officer
Officer
|
1,382
-11.0%
103.85
USD 143,516
|
1,382
-11.0%
|
103.85
|
USD 143,516
|
|
|
2021-12-10 |
2021-12-10 |
PS
Planned sale
|
Engelhart James
Chief Financial Officer
Officer
|
23,487
-65.1%
102.70
USD 2,412,162
|
23,487
-65.1%
|
102.70
|
USD 2,412,162
|
|
|
2021-12-10 |
2021-12-10 |
PS
Planned sale
|
Engelhart James
Chief Financial Officer
Officer
|
10,131
-21.9%
102.01
USD 1,033,467
|
10,131
-21.9%
|
102.01
|
USD 1,033,467
|
|
|
2021-12-01 |
2021-11-29 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
11,499
-1.3%
113.25
USD 1,302,316
|
11,499
-1.3%
|
113.25
|
USD 1,302,316
|
|
|
2021-12-01 |
2021-11-29 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
13,026
-1.5%
112.40
USD 1,464,117
|
13,026
-1.5%
|
112.40
|
USD 1,464,117
|
|
|
2021-11-17 |
2021-11-16 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
7,073
-0.8%
117.87
USD 833,711
|
7,073
-0.8%
|
117.87
|
USD 833,711
|
|
|
2021-11-17 |
2021-11-16 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
18,230
-2.0%
116.69
USD 2,127,173
|
18,230
-2.0%
|
116.69
|
USD 2,127,173
|
|
|
2021-11-17 |
2021-11-16 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
12,437
-1.3%
115.90
USD 1,441,501
|
12,437
-1.3%
|
115.90
|
USD 1,441,501
|
|
|
2021-11-10 |
2021-11-10 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
1,110
+0.0%
123.30
USD 136,862
|
1,110
+0.0%
|
123.30
|
USD 136,862
|
|
